tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
MGTA is currently covered by 2 analysts with an average price target of $16.97. This is a potential upside of $3.75 (28.37%) from yesterday's end of day stock price of $13.22.
Magenta Therapeutics's activity chart (see below) currently has 18 price targets and 17 ratings on display. The stock rating distribution of MGTA is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 25.93% with an average time for these price targets to be met of 80.44 days.
Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 16-Jul-2018.
Currently out of the existing stock ratings of MGTA, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 11 months 19 days ago
(26-Jan-2023)
0/3 (0%)
$4.08 (212.50%)
Buy
$1
$0.3 (42.86%)
$9
1 years 11 months 19 days ago
(26-Jan-2023)
0/4 (0%)
$0.56 (127.27%)
Hold
$2
$1.3 (185.71%)
$7
2 years 4 months 20 days ago
(25-Aug-2022)
1/3 (33.33%)
$0.13 (6.95%)
14
Buy
$8
$7.3 (1042.86%)
$17
2 years 8 months 27 days ago
(18-Apr-2022)
0/3 (0%)
$6.08 (316.67%)
Buy
$8
$7.3 (1042.86%)
$17
2 years 9 months ago
(14-Apr-2022)
0/2 (0%)
$5.76 (257.14%)
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?
